A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Lee, Jason J ^a   Pope, Janet E ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY;

ARTICLE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DEEP VEIN THROMBOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERCOAGULABILITY; INCIDENCE; INFLAMMATORY MYOSITIS; LUNG EMBOLISM; META ANALYSIS (TOPIC); MYOSITIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS; VENOUS THROMBOEMBOLISM; ADULT; INFLAMMATION; META ANALYSIS; PROCEDURES; RHEUMATIC DISEASES; STATISTICS AND NUMERICAL DATA;

ADULT; COMORBIDITY; HUMANS; INCIDENCE; INFLAMMATION; RHEUMATIC DISEASES; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84988857341     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0435-y     Document Type: Article

References (36)

1. White R: The epidemiology of venous thromboembolism. Circulation 2003, 107:I-4-I-8.
2. Tagalakis V, Patenaude V, Kahn S, Suissa S: Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med 2013, 126:832.e13-e21.
3. Wagner DD, Burger PC: Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003, 23:2131-2137.
4. Aviña-Zubieta JA, Lacaille D, Sayre EC, Kopec J, Choi HK, Esdaile JM: Risk of pulmonary embolism and deep vein thrombosis in systemic lupus erythematosus: a population-based cohort study. Arthritis Res Ther 2012, 14:A43.
5. Choi HK, Rho Y, Zhu Y, Cea-Soriano L, Aviña-Zubieta JA, Zhang Y: The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 2013, 72:1182-1187.
6. Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL: Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 2012, 64:53-61.
7. Holmqvist ME, Neovius M, Eriksson J, Mantel Ä, Wållberg-Jonsson S, Jacobsson LTH, Askling J: Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 2012, 308:1350-1356.
8. Calvo-Alén J, Toloza SMA, Fernández M, Bastian HM, Fessler BJ, Roseman JM, McGwin G Jr, Vilá LM, Reveille JD, Alarcón GS, the LUMINA Study Group: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum 2005, 52:2060-2068.
9. Kaiser R, Cleveland CM, Criswell LA: Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis 2009, 68:238-241.
10. Burgos PI, McGwin G Jr, Reveille JD, Vilá LM, Alarcón GS: Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). Rheumatology 2010, 49:1720-1725.
11. Agresti A, Coull B: Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 1998, 52:119-126.
12. Wilson E: Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927, 22:209-212.
13. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
14. Higgins JPT, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
15. Aviña-Zubieta J, Hemmati I, Sayre EC, Shojania K, Choi HK: The risk of pulmonary embolism and deep venous thrombosis in systemic sclerosis: a populationbased cohort study [Abstract 1814]. Arthritis Rheum 2013, 65:S774.
16. Matta F, Singala R, Yaekoub A, Najjar R, Stein P: Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009, 101:134-138.
17. Liang KP, Liang KV, Matteson EL, McClelland RL, Christianson TJH, Turesson C: Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis Rheum 2006, 54:642-648.
18. Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, Sung FC, Kao CH: Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 2014, 73:1774-1780.
19. Kim S, Schneeweiss S, Liu J, Solomon D: Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res 2013, 65:1600-1607.
20. Romero-Díaz J, García-Sosa I, Sánchez-Guerrero J: Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol 2009, 36:68-75.
21. Zöller B, Li X, Sundquist J, Sundquist K: Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2012, 379:244-249.
22. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ: Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011, 9:1.
23. Sarabi ZS, Chang E, Bobba R, Ibanez D, Gladman D, Urowitz M, Fortin PR: Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Care Res 2005, 53:609-612.
24. Chang E, Pineau C, Bernatsky S, Neville C, Clarke A, Fortin P: Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus. J Rheumatol 2006, 33:1780-1784.
25. Gladman DD, Urowitz MB: Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis 1980, 39:340-343.
26. Haga H, Jacobsen EM, Peen E: Incidence of thromboembolic events in patients with primary Sjögren's syndrome. Scand J Rheumatol 2008, 37:127-129.
27. Selva-O'Callaghan A, Fernández-Luque A, Martínez-Gómez X, Labirua-Iturburu A, Vilardell-Tarrés M: Venous thromboembolism in patients with dermatomyositis and polymyositis. Clin Exp Rheumatol 2011, 29:846-849.
28. Stassen PM, Derks RPH, Kallenberg CGM, Stegeman CA: Venous thromboembolism in ANCA-associated vasculitis-incidence and risk factors. Rheumatology 2008, 47:530-534.
29. Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC Jr, Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Petri M, Stone JH, Wegener's Granulomatosis Etanercept Trial Research Group: Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med 2005, 142:620-626.
30. Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, the French Vasculitis Study Group: High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 2009, 68:564-567.
31. Chung WS, Lin CL, Sung FC, Hsu WH, Chen YF, Kao CH: Increased risks of deep vein thrombosis and pulmonary embolism in Sjögren syndrome: a nationwide cohort study. J Rheumatol 2014, 41:909-915.
32. Chung WS, Lin CL, Chang SN, Lu CC, Kao CH: Systemic lupus erythematosus increases the risks of deep vein thrombosis and pulmonary embolism: a nationwide cohort study. J Thromb Haemostasis 2014, 12:452-458.
33. Chung WS, Lin CL, Sung FC, Hsu WH, Yang WT, Lu CC, Kao CH: Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Rheumatology (Oxford) 2014, 53:1639-1645.
34. Petri M: Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 1996, 5:S16-S22.
35. Law G, Magder LS, Fang H, Petri M: Hydroxychloroquine reduces thrombosis (both arterial and venous) in systemic lupus erythematosus, particularly in antiphospholipid positive patients [Abstract 2569]. Arthritis Rheum 2012, 64:S1086-S1087.
36. Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, Forastiero R, Pengo V, Lambert M, Martinez-Zamora M, Balasch J, Zuily S, Wahl D, Amoura Z: Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 2014, 13:281-291.